Leadership Overview
Eurofins has 10 executives leading key functions including regional operations, technology, financial management, and specialized laboratory services.
Committed to advancing global health through rigorous scientific analysis, Eurofins delivers essential testing solutions that ensure safety and quality across the pharmaceutical, food, and environmental sectors worldwide.
Committed to advancing global health through rigorous scientific analysis, Eurofins delivers essential testing solutions that ensure safety and quality across the pharmaceutical, food, and environmental sectors worldwide.
Leadership Roles at Eurofins
Alexandra Kim - Chief Financial Officer, Business Line
Alexandra Kim, the Chief Financial Officer, Business Line at Eurofins, manages the financial health and fiscal strategy for specific business units. This role involves overseeing budgeting, forecasting, and capital allocation to support the growth of analytical testing services. By analyzing financial performance metrics, the Chief Financial Officer, Business Line ensures that operational investments align with the broader corporate objectives. Alexandra Kim drives cost-efficiency initiatives that improve profit margins while maintaining the high quality of laboratory services. This leadership position requires close collaboration with operational heads to monitor revenue streams and manage financial risks effectively. Through the implementation of robust financial controls, Kim supports the sustainable expansion of the business line. The Chief Financial Officer, Business Line provides critical insights that inform strategic decision-making at the executive level. Ultimately, Alexandra Kim ensures the financial stability and long-term viability of the business unit through disciplined fiscal management.
Jatin Vij - Chief Financial Officer, Business Lines (Multiple, Asia)
Jatin Vij, the Chief Financial Officer, Business Lines (Multiple, Asia) at Eurofins, directs the financial operations across diverse business units within the Asian market. This role involves managing complex fiscal structures to support the rapid scaling of laboratory and testing services. By overseeing regional financial planning and analysis, the Chief Financial Officer, Business Lines (Multiple, Asia) ensures that resources are allocated to maximize growth in the clinical diagnostics and environmental sectors. Jatin Vij drives strategies to optimize cash flow and mitigate financial risks associated with international operations. This leadership position requires constant coordination with regional directors to align financial performance with corporate targets. Through the application of rigorous accounting standards, Vij maintains transparency and fiscal discipline across all Asian business lines. The Chief Financial Officer, Business Lines (Multiple, Asia) provides the financial foundation necessary for sustained market penetration. Ultimately, Jatin Vij secures the economic health of the regional portfolio.
Camila Gadotti - President
Camila Gadotti, the President at Eurofins, leads the strategic direction and operational execution for the assigned business division. This role involves overseeing the delivery of specialized analytical testing services to ensure compliance with global safety standards. By driving organizational growth, the President fosters a culture of scientific excellence and operational efficiency. Camila Gadotti collaborates with other executive leaders to integrate new service offerings into the existing laboratory network. This leadership position requires a deep understanding of market dynamics within the life sciences sector to anticipate client needs effectively. Through the management of high-performing teams, Gadotti ensures that the division meets its performance targets and maintains a strong market position. The President focuses on scaling operations to support the increasing demand for clinical and environmental testing. Ultimately, Camila Gadotti drives the long-term success of the division by prioritizing innovation, quality, and client-focused service delivery.
Andrew Buschow - President of Eurofins Rapid Microbiology Laboratories
Andrew Buschow, the President of Eurofins Rapid Microbiology Laboratories at Eurofins, directs the specialized operations of the rapid microbiology division. This role involves overseeing the development and implementation of accelerated testing protocols for the food and pharmaceutical industries. By driving the adoption of rapid diagnostic technologies, the President of Eurofins Rapid Microbiology Laboratories ensures that clients receive critical safety data with minimal turnaround time. Andrew Buschow manages the laboratory infrastructure to maintain high throughput and strict adherence to regulatory standards. This leadership position requires constant innovation to improve the speed and accuracy of microbiological testing. Through the coordination of technical teams, Buschow supports the expansion of the division's service capabilities. The President of Eurofins Rapid Microbiology Laboratories collaborates with other business units to provide comprehensive testing solutions. Ultimately, Andrew Buschow secures the division's leadership in the rapid testing market by delivering reliable, high-speed analytical results.

James Jung - President
James Jung, the President at Eurofins, oversees the strategic management and operational performance of the assigned business unit. This role involves driving the expansion of analytical testing services to meet the evolving needs of the pharmaceutical and consumer product sectors. By managing the division's resources, the President ensures that laboratory operations remain efficient and compliant with international quality standards. James Jung collaborates with cross-functional teams to implement new testing methodologies that enhance service quality. This leadership position requires a focus on market growth and the identification of new business opportunities within the life sciences industry. Through the application of strategic planning, Jung aligns the division's output with the broader corporate mission. The President monitors key performance indicators to ensure that the business unit achieves its financial and operational goals. Ultimately, James Jung drives the division's success by fostering a commitment to scientific precision and operational excellence.
Marisa Feller - President
Marisa Feller, the President at Eurofins, directs the operational and strategic initiatives for the designated business division. This role involves overseeing the delivery of high-quality laboratory services to support clinical diagnostics and environmental testing. By driving process improvements, the President ensures that the division maintains its competitive edge in the life sciences market. Marisa Feller collaborates with other executive leaders to synchronize service delivery with global corporate objectives. This leadership position requires a focus on scaling operations to meet the increasing demand for analytical support. Through the management of diverse teams, Feller fosters an environment of innovation and scientific rigor. The President monitors market trends to adjust the division's strategy and ensure long-term growth. By prioritizing client satisfaction and operational efficiency, the division achieves its performance targets. Ultimately, Marisa Feller secures the division's market position by delivering reliable, high-quality testing solutions that meet the highest industry standards.
Charles Byrne - President
Charles Byrne, the President at Eurofins, manages the strategic operations and business development for the assigned division. This role involves overseeing the provision of analytical testing and laboratory support services to ensure safety and quality for clients. By driving operational efficiency, the President ensures that the division meets its performance goals while maintaining strict regulatory compliance. Charles Byrne collaborates with other executive leaders to integrate new testing capabilities into the existing service portfolio. This leadership position requires a focus on market expansion and the development of long-term client relationships. Through the application of strategic management, Byrne aligns the division's activities with the broader corporate mission of advancing global health. The President monitors operational metrics to optimize resource allocation and improve service delivery. Ultimately, Charles Byrne drives the division's success by fostering a culture of scientific excellence and ensuring the consistent delivery of high-quality analytical results.
Scott Fyfe - Chief Technology Officer
Scott Fyfe, the Chief Technology Officer at Eurofins, architects the digital infrastructure supporting the global network of laboratories. This role involves implementing advanced automation and data management systems to streamline analytical testing processes. By driving the adoption of cutting-edge software solutions, the Chief Technology Officer enhances the precision and speed of diagnostic services. Scott Fyfe collaborates with laboratory managers to integrate new technologies that improve operational efficiency across the pharmaceutical and consumer product sectors. This leadership position requires constant evaluation of emerging tech trends to maintain a competitive edge in the life sciences industry. Through the development of scalable digital platforms, Fyfe ensures that the company remains at the forefront of scientific innovation. The Chief Technology Officer manages the technical roadmap to support long-term growth and operational stability. Ultimately, Scott Fyfe secures the technological foundation necessary for delivering accurate, high-quality scientific support services globally.
Abedulfattah Al Rawwas - Regional Managing Director
Abedulfattah Al Rawwas, the Regional Managing Director at Eurofins, directs all operational activities across the assigned territory. This leadership role involves scaling laboratory capacity to meet increasing demand for analytical testing services. By optimizing regional workflows, Al Rawwas ensures that testing facilities maintain high throughput while adhering to strict quality standards. The Regional Managing Director coordinates with global leadership to align local output with the broader corporate mission of providing comprehensive scientific support. Through the implementation of advanced diagnostic protocols, Abedulfattah Al Rawwas drives efficiency and enhances service delivery for clients in the pharmaceutical and food sectors. This position requires constant monitoring of market trends to adjust operational strategies effectively. Ultimately, the Regional Managing Director secures the competitive position of the company by fostering innovation and maintaining operational excellence across all regional testing sites.
Karthik Nd - Regional Managing Director
Karthik Nd, the Regional Managing Director at Eurofins, oversees the strategic expansion of laboratory networks within the designated market. This role focuses on integrating new testing technologies to support clinical diagnostics and environmental monitoring. By managing cross-functional teams, the Regional Managing Director ensures that all laboratory operations meet rigorous regulatory requirements. Karthik Nd drives initiatives to improve turnaround times for complex analytical projects, directly impacting client satisfaction and market growth. The Regional Managing Director collaborates with other executive leaders to synchronize regional performance with global objectives. Through the application of data-driven management techniques, Nd optimizes resource allocation and enhances the overall productivity of the regional infrastructure. This leadership function remains critical for maintaining the high standards of scientific integrity expected by the company. Ultimately, Karthik Nd strengthens the regional footprint by delivering reliable, high-quality testing services to diverse industrial sectors.
Explore Leadership Teams in Business Services
The Agency for Science, Technology and Research, also known as A*STAR, is a research organization that advances national priorities in health, economy, sustainability, and future technologies. The agency conducts scientific research and innovation across diverse fields, including electronics, cancer research, chemistry, water treatment, materials science, infectious diseases, genetics, and energy. Its work focuses on developing impactful science, such as energy-efficient AI systems, sustainable molecular catalysts, and novel RNA-based molecular tools, to drive research, innovation, and enterprise in the physical sciences and engineering.
Company Leadership
MJ
WK
Velocity Clinical Research, headquartered in Durham, NC, is a leading integrated site organization for clinical trials, offering dedicated site capabilities to help biopharmaceutical and contract research organization customers find the right patients for their studies.
Company Leadership GC

BL
CTI was founded in 1999 to provide therapeutic expertise to the pharmaceutical and biotechnology industry across a range of services. They have experienced consistent and significant growth from a US-based organization to a multi-national corporation.
Company Leadership JB

MM
Founded in 1930, The Woods Hole Oceanographic Institution is a non-profit organization that supports marine research, engineering, and higher education. Woods Hole Oceanographic Institution is headquartered in Woods Hole, Massachusetts.
Company Leadership FS
KG
SH
